Multiple Sclerosis Ms News Today

The novel ultrasound device resolved lingering kidney stones and prevented relapse in a new study.

Real-world US claims-based data show major gaps in the care and management of three major neurologic diseases – Alzheimer's, Parkinson's, and multiple sclerosis.

A unique autoantibody signature of multiple sclerosis may predict the disease years before individuals become symptomatic.

Low-quality evidence shows using cannabis can help neuropathic pain, multiple sclerosis-associated spasticity, and chemo-induced nausea or vomiting. For most other problems, the effects are unclear.

The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Behçet's disease.

Many clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.

There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint inhibitor therapy, results of a small study suggest.

Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?

Early initiation of HET in pediatric-onset MS was linked to slower progression to disability compared to treatment with low-efficacy therapy or no treatment.

Two classes of pervasive environmental chemicals that are present in household cleaners, furniture and electronics had "surprising" effects specifically on the non-nerve cells in the brain.